Darapladib-impurity

TargetMol
Product Code: TAR-T31204
Supplier: TargetMol
CodeSizePrice
TAR-T31204-1mg1mg£227.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31204-5mg5mg£430.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31204-10mg10mg£600.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31204-25mg25mg£863.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31204-50mg50mg£1,179.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31204-100mg100mg£1,589.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T31204-500mg500mg£3,115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20°C

Images

1 / 1

Further Information

Bioactivity:
Darapladib-impurity is the impurity of Darapladib. Darapladib inhibits lipoprotein-associated phospholipase A2 (Lp-PLA2).
CAS:
1389264-17-8
Molecular Weight:
666.77
Purity:
0.9804
SMILES:
O=C(N(CC1=CC=C(C=C1)C=2C=CC(=CC2)C(F)(F)F)CCN(CC)CC)COC3=NC(=NC4=C3CCC4)SCC5=CC=C(F)C=C5

References

Moneeza K Siddiqui, et al.Diabetes status modifies the long-term effect of lipoprotein-associated phospholipase A2 on major coronary events.Clinical Trial Diabetologia. 2022 Jan;65(1):101-112.